GlassScriptPrepare for your visit
Michael S Borkin
Dermatology · Birmingham, MI · NPI 1194089169
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,679.98
in general payments reported to CMS, 2019-2025 · $1,168 in 2025
The $1,168 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,003.52
- Janssen Biotech, INC. $928.65
- Genzyme Corporation $503.65
- Ortho Dermatologics, A Division of Bausch Health US, LLC $500.87
- Regeneron Healthcare Solutions, INC. $462.65
- Sun Pharmaceutical Industries INC. $381.31
Drugs and devices associated with these payments
Dupixent Tremfya Rinvoq Vtama Adbry Skyrizi Cibinqo Taltz Cosentyx Bimzelx Litfulo Sotyktu
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Borkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/281075/michael-s-borkin